CGC
Price
$1.24
Change
-$0.07 (-5.34%)
Updated
Dec 26, 02:30 PM (EDT)
Capitalization
445.03M
42 days until earnings call
Intraday BUY SELL Signals
SNOA
Price
$3.64
Change
+$0.06 (+1.68%)
Updated
Dec 24 closing price
Capitalization
6.19M
Intraday BUY SELL Signals
Interact to see
Advertisement

CGC vs SNOA

Header iconCGC vs SNOA Comparison
Open Charts CGC vs SNOABanner chart's image
Canopy Growth
Price$1.24
Change-$0.07 (-5.34%)
Volume$600
Capitalization445.03M
Sonoma Pharmaceuticals
Price$3.64
Change+$0.06 (+1.68%)
Volume$7.14K
Capitalization6.19M
CGC vs SNOA Comparison Chart in %
View a ticker or compare two or three
VS
CGC vs. SNOA commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGC is a Buy and SNOA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (CGC: $1.31 vs. SNOA: $3.64)
Brand notoriety: CGC: Notable vs. SNOA: Not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CGC: 48% vs. SNOA: 26%
Market capitalization -- CGC: $445.03M vs. SNOA: $6.19M
CGC [@Pharmaceuticals: Generic] is valued at $445.03M. SNOA’s [@Pharmaceuticals: Generic] market capitalization is $6.19M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGC’s FA Score shows that 0 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • CGC’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGC’s TA Score shows that 6 TA indicator(s) are bullish while SNOA’s TA Score has 4 bullish TA indicator(s).

  • CGC’s TA Score: 6 bullish, 4 bearish.
  • SNOA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CGC is a better buy in the short-term than SNOA.

Price Growth

CGC (@Pharmaceuticals: Generic) experienced а -31.77% price change this week, while SNOA (@Pharmaceuticals: Generic) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.58%. For the same industry, the average monthly price growth was +8.11%, and the average quarterly price growth was +22.96%.

Reported Earning Dates

CGC is expected to report earnings on Feb 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.58% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($445M) has a higher market cap than SNOA($6.19M). SNOA YTD gains are higher at: 35.316 vs. CGC (-52.190). SNOA has higher annual earnings (EBITDA): -2.98M vs. CGC (-294.03M). CGC has more cash in the bank: 298M vs. SNOA (3.04M). SNOA has less debt than CGC: SNOA (535K) vs CGC (259M). CGC has higher revenues than SNOA: CGC (279M) vs SNOA (16.9M).
CGCSNOACGC / SNOA
Capitalization445M6.19M7,187%
EBITDA-294.03M-2.98M9,857%
Gain YTD-52.19035.316-148%
P/E RatioN/AN/A-
Revenue279M16.9M1,651%
Total Cash298M3.04M9,819%
Total Debt259M535K48,411%
FUNDAMENTALS RATINGS
CGC vs SNOA: Fundamental Ratings
CGC
SNOA
OUTLOOK RATING
1..100
165
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
5845
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
5025

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNOA's Valuation (65) in the Pharmaceuticals Other industry is in the same range as CGC (94) in the Agricultural Commodities Or Milling industry. This means that SNOA’s stock grew similarly to CGC’s over the last 12 months.

SNOA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that SNOA’s stock grew similarly to CGC’s over the last 12 months.

SNOA's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as CGC (98) in the Agricultural Commodities Or Milling industry. This means that SNOA’s stock grew similarly to CGC’s over the last 12 months.

SNOA's Price Growth Rating (45) in the Pharmaceuticals Other industry is in the same range as CGC (58) in the Agricultural Commodities Or Milling industry. This means that SNOA’s stock grew similarly to CGC’s over the last 12 months.

SNOA's P/E Growth Rating (55) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (100) in the Agricultural Commodities Or Milling industry. This means that SNOA’s stock grew somewhat faster than CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CGCSNOA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CGC
Daily Signal:
Gain/Loss:
SNOA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCC74.711.48
+2.02%
Boise Cascade Company
LYTS19.000.29
+1.55%
LSI Industries
ALB148.511.81
+1.23%
Albemarle Corp
EXOZ12.470.08
+0.65%
eXoZymes Inc
RDHL1.15-0.03
-2.95%
Redhill Biopharma Ltd

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
-6.43%
SNDL - CGC
77%
Closely correlated
-0.56%
ACB - CGC
67%
Closely correlated
-1.72%
CRON - CGC
64%
Loosely correlated
-0.36%
TLRY - CGC
63%
Loosely correlated
-3.61%
OGI - CGC
63%
Loosely correlated
+1.15%
More

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and CRDL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and CRDL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
+1.68%
CRDL - SNOA
29%
Poorly correlated
+1.00%
BNXTF - SNOA
29%
Poorly correlated
+3.89%
BGLAF - SNOA
27%
Poorly correlated
N/A
AKAN - SNOA
25%
Poorly correlated
-10.83%
CGC - SNOA
24%
Poorly correlated
-6.43%
More